FDA NDC
Adalimumab
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 61314-391
- Proprietary name
- Adalimumab
- Nonproprietary name
- adalimumab-adaz
- Labeler
- Sandoz Inc
- Dosage form
- INJECTION, SOLUTION
- Strength
- 10 mg/.1mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted adalimumab-adaz?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.